# Pharmacokinetic Parameters of Stiripentol in Renal Impaired Patients and Matching Controls With Normal Renal Function

> **NCT05735951** · PHASE1 · COMPLETED · sponsor: **Biocodex** · enrollment: 39 (actual)

## Conditions studied

- Chronic Renal Insufficiency

## Interventions

- **DRUG:** STIRIPENTOL oral administration

## Key facts

- **NCT ID:** NCT05735951
- **Lead sponsor:** Biocodex
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-24
- **Primary completion:** 2024-11-30
- **Final completion:** 2024-11-30
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2025-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05735951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05735951, "Pharmacokinetic Parameters of Stiripentol in Renal Impaired Patients and Matching Controls With Normal Renal Function". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05735951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*